These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31435920)
1. A Method for Targeted Nonviral siRNA Delivery in Cancer and Inflammatory Diseases. Kandil R; Xie Y; Mehta A; Merkel O Methods Mol Biol; 2020; 2059():155-166. PubMed ID: 31435920 [TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma. Xie Y; Kim NH; Nadithe V; Schalk D; Thakur A; Kılıç A; Lum LG; Bassett DJP; Merkel OM J Control Release; 2016 May; 229():120-129. PubMed ID: 27001893 [TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine. Xie Y; Killinger B; Moszczynska A; Merkel OM Molecules; 2016 Oct; 21(10):. PubMed ID: 27735873 [TBL] [Abstract][Full Text] [Related]
4. Targeted siRNA Delivery Using a Lipo-Oligoaminoamide Nanocore with an Influenza Peptide and Transferrin Shell. Zhang W; Müller K; Kessel E; Reinhard S; He D; Klein PM; Höhn M; Rödl W; Kempter S; Wagner E Adv Healthc Mater; 2016 Jun; 5(12):1493-504. PubMed ID: 27109317 [TBL] [Abstract][Full Text] [Related]
5. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968 [TBL] [Abstract][Full Text] [Related]
6. Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma. Kandil R; Baldassi D; Böhlen S; Müller JT; Jürgens DC; Bargmann T; Dehmel S; Xie Y; Mehta A; Sewald K; Merkel OM J Control Release; 2023 Feb; 354():305-315. PubMed ID: 36634709 [TBL] [Abstract][Full Text] [Related]
7. Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles. Movassaghian S; Xie Y; Hildebrandt C; Rosati R; Li Y; Kim NH; Conti DS; da Rocha SR; Yang ZQ; Merkel OM Mol Pharm; 2016 Aug; 13(8):2605-21. PubMed ID: 27223606 [TBL] [Abstract][Full Text] [Related]
8. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bartlett DW; Davis ME Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672 [TBL] [Abstract][Full Text] [Related]
9. Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth. Liu Y; Tao J; Li Y; Yang J; Yu Y; Wang M; Xu X; Huang C; Huang W; Dong J; Li L; Liu J; Shen G; Tu Y Mol Ther; 2009 Feb; 17(2):269-77. PubMed ID: 19066596 [TBL] [Abstract][Full Text] [Related]
10. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
11. omega-Hydrazino linear polyethylenimine: a monoconjugation building block for nucleic acid delivery. Pons B; Mouhoubi L; Adib A; Godzina P; Behr JP; Zuber G Chembiochem; 2006 Feb; 7(2):303-9. PubMed ID: 16416489 [TBL] [Abstract][Full Text] [Related]
12. Combination of sequence-defined oligoaminoamides with transferrin-polycation conjugates for receptor-targeted gene delivery. Zhang W; Rödl W; He D; Döblinger M; Lächelt U; Wagner E J Gene Med; 2015; 17(8-9):161-72. PubMed ID: 26227403 [TBL] [Abstract][Full Text] [Related]
13. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728 [TBL] [Abstract][Full Text] [Related]
14. Polyethylenimines for siRNA and miRNA delivery in vivo. Höbel S; Aigner A Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168 [TBL] [Abstract][Full Text] [Related]
16. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine. Shim MS; Kwon YJ J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289 [TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted gene transfer with DNA polyplexes. Ogris M; Wagner E Somat Cell Mol Genet; 2002 Nov; 27(1-6):85-95. PubMed ID: 12774943 [TBL] [Abstract][Full Text] [Related]
18. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery. Youn P; Chen Y; Furgeson DY Mol Pharm; 2014 Feb; 11(2):486-95. PubMed ID: 24387132 [TBL] [Abstract][Full Text] [Related]
19. Systemic in vivo delivery of siRNA to tumours using combination of polyethyleneimine and transferrin-polyethyleneimine conjugates. Grabowska AM; Kircheis R; Kumari R; Clarke P; McKenzie A; Hughes J; Mayne C; Desai A; Sasso L; Watson SA; Alexander C Biomater Sci; 2015 Nov; 3(11):1439-48. PubMed ID: 26351701 [TBL] [Abstract][Full Text] [Related]
20. Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy. Nie Y; Schaffert D; Rödl W; Ogris M; Wagner E; Günther M J Control Release; 2011 May; 152(1):127-34. PubMed ID: 21392549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]